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West Nile virus (WNV) antibodies were detected in
horses from five Mexican states, and WNV was isolated
from a Common Raven in the state of Tabasco.
Phylogenetic studies indicate that this isolate, the first from
Mexico, is related to strains from the central United States
but has a relatively high degree of sequence divergence.
D
uring the summer of 2002, the Agricultural Ministry
of Mexico (SAGARPA) received reports of
encephalitis-like illness in horses from several different
areas of Mexico, concurrent with reports of West Nile
virus (WNV) encephalitis outbreaks in horses along the
Texas border in the states of Coahuila, Tamaulipas, and
Chihuahua. Other suspected cases were reported from sev-
eral southern, tropical states. We report the results of an
equine serosurvey conducted from July 2002 to March
2003 by the Office of Exotic Diseases of the Agricultural
Ministry (CPA-SAGARPA). We also describe the first iso-
lation of WNV in Mexico, in a Common Raven (Corvus
corax) from the state of Tabasco.
The Republic of Mexico is divided by the Tropic of
Cancer, with temperate, arid climate zones in the north and
at higher elevations and humid, subtropical, and tropical
climate zones in the south. Our study encompassed most of
these climatic zones, as equine serum samples were col-
lected from 3 border states, 1 state on the Tropic of Cancer,
and 10 states south of the Tropic of Cancer (Figure 1).
Sampled equine populations were chosen on the basis of a
history of clinical encephalitis; medical history was pro-
vided by owners and corroborated by CPA-SAGARPAvet-
erinarians. In total, 441 serum samples were analyzed for
WNV antibodies. 
Because most serum samples were collected late in the
probable virus transmission season, all were first screened
for immunoglobulin (Ig) G antibodies, using IgG enzyme-
linked immunosorbent assays (ELISA) with a recombi-
nant, envelope protein domain III antigen expressed and
purified from Escherichia coli (D.W.C. Beasley, et al.,
submitted for pub.). Positive samples were confirmed by
hemagglutination inhibition (HI) tests against WNV and
St. Louis encephalitis virus (SLEV), by 90% plaque reduc-
tion neutralization tests (PRNT) against WNV (1), and by
ELISA with WNV, SLEV, and Venezuelan equine
encephalitis virus (VEEV) antigens and viruses. (The pres-
ence of several endemic arboviruses, including SLEV and
VEEV, necessitated additional testing.) WNV infection
was confirmed if the WNV antibody titer was >fourfold
higher than the SLEV titer. To investigate evidence of
recent WNV infection, 198 samples were also tested by
using both IgG- and IgM-specific ELISA with WNV-
infected cell culture antigens (2). Selected samples were
tested by ELISA and PRNT for VEEV antibodies to deter-
mine if this virus was circulating in areas reporting equine
encephalitis.
Results
A total of 441 equine serum samples from 14 states of
Mexico were tested (Figure 1). WNV-specific antibodies
were detected in 97 (22%) of the samples. These data prob-
ably overestimate the true equine seropositivity rate
because sampling focused on herds with a history of clini-
cal encephalitis. Representative data from 22 of the WNV-
positive samples obtained in five different states are pre-
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Figure 1. Map showing the Mexican states sampled for antibodies
to West Nile virus and Venezuelan equine encephalitis virus in
equines. Unshaded states were not sampled. The location of the
West Nile virus isolation from a dead Common Raven is shown by
a star.sented in Table 1. No evidence was obtained of SLEV
infection in equines, but VEEV-specific antibodies were
detected in serum samples from the states of Veracruz and
Yucatán. (Horses are vaccinated against VEEV in the
states of Chiapas and Oaxaca, so samples from these loca-
tions were not tested for VEEV antibodies.) The positive
samples, several of which also contained WNV IgG, repre-
sent natural VEEV circulation and infection of horses, pre-
sumably with enzootic subtype IE strains (3,4).
On May 5, 2003, the CPA-SAGARPAreceived a report
of a dead Common Raven from the El Yumka wildlife pre-
serve in the city of Villahermosa, state of Tabasco.
Although this species is native to Tabasco and other
regions of Mexico, this bird was one of two ravens im-
ported from the United States in 1999. Anecropsy was per-
formed, and virus isolation was attempted on tissue sam-
ples at the CPA-SAGARPA biosafety level 3 facility in
Palo Alto, Mexico City. On May 16, 2003, cytopathic
effects were detected in Vero cells injected with brain sus-
pension. Viral RNA from the isolate was genetically char-
acterized at the National Institute for Epidemiology and
Diagnostics (InDre) in Mexico City and at the University
of Texas Medical Branch in Galveston. A2,004-nt genome
portion, including the prM-E protein region, was amplified
by using a reverse transcription–polymerase chain reaction
as described previously (5); the resulting amplicons were
sequenced directly with the Big Dye sequencing kit and
model 3100 sequencer (Applied Biosystems, Foster City,
CA). The sequence of this WNV isolate (TM171-03, sub-
mitted to GenBank under accession no. AY371271) was
aligned with all homologous WNV sequences of the same
length available from the GenBank library (homologous to
nt 466–2,469 in the Flamingo382 strain, GenBank acces-
sion no. AF196835), and phylogenetic trees were con-
structed by using maximum parsimony, maximum likeli-
hood (incorporating empirical base frequencies, a general
time-reversible substitution model with the following fre-
quencies: A→C 1.34263; A→G 4.18575; A→U 1.55497;
C→G 0.044980; C→T 15.08737; G→U 1.00000, a
g shape parameter of 0.228), and neighbor joining pro-
grams implemented in the PAUP 4.0 software package (6).
All trees had nearly identical branching orders; the maxi-
mum parsimony tree is presented in Figure 2. All trees
placed the Mexican raven isolate as a sister to a clade that
comprises most WNV strains isolated in Texas during
2002. Two other WNV strains from the Bolivar Peninsula,
Texas (362, 476), were positioned basally to a 1998 Israeli
stork isolate that grouped with all other North American
isolates, suggesting that the North American strains may
not all have originated from a point source introduction
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Table 1. Serologic analysis
a of 22 horse serum samples from five Mexican states, positive for West Nile virus antibodies, July 2002–
March 2003
b 
  WNV serologic findings 
State, locality  Sample no.  Date  Age  Sex  IgG-E  IgM  IgG  PRNT  HI  HI SLEV 
Veracruz, Minatitlan  VER-015  Oct 28, 2002  7 y  M  pos  1,600  400  >320  20  20 
Veracruz, Minatitlan  VER-011  Oct 28, 2002  18 m  M  pos  neg  400  >320  160  neg 
Veracruz, Hidalgotitlan  VER-017  Oct 29, 2002  8 m  M  pos  12,800  neg  >320  >640  160 
Veracruz, Texistepec   VER-26  Oct 29, 2002  2 y  M  pos  neg  100  40  160  neg 
Veracruz, Texistepec  VER-025  Nov 7, 2002  18 m  M  pos  6,400  neg  >320  >640  160 
Veracruz, J. Carranza  VER-036  Nov 11, 2002  7 m  M  pos  neg  6,400  >320  >640  40 
Veracruz, Angel R. Cabada  406  Mar 20, 2003  13 m  F  pos  neg  400  >320  80  neg 
Veracruz, Cosamaloapan  187  Aug 28, 2002  5 y  F  pos  neg  1,600  >320  160  20 
Yucatan, Merida  389  Mar 7, 2003  4 y  F  pos  neg  1,600  nt  80  20 
Yucatan, Tizimin  391  Mar 1, 2003  5 y  M  pos  neg  1,600  160  40  20 
Chihuahua, Ojinaga  210  Oct 20, 2002  2 y  M  neg  1,600  neg  40  320  40 
Coahuila, Cd Acuna  112  Oct 14, 2002  3 y  M  pos  1,600  neg  80  20  20 
Coahuila, Hidalgo  4  Sep 1, 2002  5  F  pos  400  100  >320  >640  20 
Coahuila, Villa Union  26  Nov 2, 2002  4 y  M  pos  400  100  >320  320  80 
Coahuila, Nava  67  Jul 11, 2002  7 y  M  pos  400  100  >320  320  20 
Coahuila, P. Negras  56  Nov 5, 2002  2 y  M  pos  6,400  100  >320  >640  40 
Coahuila, Zaragoza  39  Oct 10, 2002  5 y  F  pos  neg  400  >160  320  20 
Coahuila, Morelos  51  Oct 5, 2002  7 y  M  pos  neg  100  >160  160  40 
Tamaulipas, Diaz Ordaz  268  Nov 7, 2002  8 y  F  pos  12,800  1,600  40  320  40 
Tamaulipas, Camargo  279  Nov 11, 2002  4 y  F  pos  12,800  3,200  >320  320  80 
Tamaulipas, Rio Bravo  349  Nov 5, 2002  8 y  M  pos  neg  400  80  80  neg 
Tamaulipas, Victoria  344  Nov 7, 2002  2 y  M  pos  neg  6,400  >320  160  20 
aTiters expressed as reciprocal of dilution; all tests were enzyme-linked immunosorbent assays unless otherwise noted; all tests were against WNV (West Nile virus) 
unless otherwise noted.  
bSLEV, St. Louis encephalitis virus; Ig, immunoglobin; G-E, recombinant domain III of E protein; PRNT, plaque reduction neutralization test; HI, hemagglutination 
inhibition test. into the New York area in 1999. This topologic finding was
the result of a single synonymous, third codon position
(genomic position 969 by using the numbering of the
Flamingo382 isolate, GenBank accession no. AF196835)
U nucleotide (synapomorphy) shared by the 1998 Israeli
and all North American strains except the Bolivar
Peninsula isolates. However, the relatively poor support,
represented by bootstrap values (1,000 replicates) of only
56–59 by using the three different phylogenetic methods,
suggests that this topologic finding is not necessarily cor-
rect. More robust phylogenetic analyses using complete
genomic sequences are needed to clarify these relation-
ships.
Comparison of nucleotide sequences indicated muta-
tions at 9 nt (0.45%) of the Mexican TM171-03 sequence
compared to the prototype NY99 strain (Flamingo382,
GenBank accession no. AF196835). Some of these
nucleotide positions vary among other strains sampled
worldwide, suggesting that they are not under strong puri-
fying selection. Comparison with sequences of Year 2002
Texas strains showed only one shared mutation (genomic
position 2466 C→U). WNV has remained genetically con-
served in the New World; however, based on our limited
sequencing, the Mexican strain appears to be the most
divergent WNV isolate identified to date in the Americas
(Table 2). Two of the mutations resulted in amino acid
changes at prM141 (Ile→Thr) and E156 (Ser→Pro),
which have not been reported to date in North American
isolates. The Ser→Pro amino acid substitution at residue
E156 is of interest, as it abolishes a potential glycosylation
site that is a putative WNV virulence determinant (7–9).
This report is the first of a New World WNV isolate with
probable altered E protein glycosylation. Further studies
are in progress to assess the possible phenotypic effects of
this mutation.
Conclusions
Two recent publications reported serologic evidence of
WNV infection among equines in the states of Yucatán and
Coahuila from serum samples collected beginning in July
and December 2002, respectively (10,11). We obtained
serologic evidence of more widespread circulation of
WNV in five other Mexican states, also dating back to July
2002. We also report the first isolation of WNV from
Mexico from a dead Common Raven that resided in a
wildlife preserve in Tabasco. 
Genetic studies indicated that the Mexican WNV strain
was likely introduced from the central United States. The
level of genetic divergence (9 nt) of the Mexican isolate
and the unique amino acid substitutions in the prM and E
proteins when compared to all other North American
WNV isolates suggest that the Mexican strain has been
evolving independently for some time and did not simply
enter Mexico recently from Texas. We speculate that this
strain descended from a WNV strain introduced into the
Yucatán peninsula by migrating birds. Nucleotide
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Figure 2. Phylogenetic tree, derived by maximum likelihood (ML) by using prM-E sequences for West Nile virus (WNV) isolates includ-
ing the 2003 Mexican Raven isolate. Strains are indicated by country or abbreviated state (U.S.) followed by year and strain designation.
GenBank accession nos. are in parentheses. A lineage 2 WNV strain (AY277251) was used to root the tree. Numbers indicate bootstrap
values from 1,000 replicates. 
Table 2. Nucleotide and deduced amino acid differences in the 
prM-E gene region between the prototype New York (382-99)  
and Mexican (TM171-03) West Nile virus strains 
Nucleotide (amino acid)
a  Strain 382-99  Strain TM171-03 
483  C  U 
858  C  U 
887 (prM141)  U (Ile)  C (Thr) 
1137  C  U 
1432 (E156)  U (Ser)  C (Pro) 
1626  C  U 
2328  C  U 
2388  C  U 
2466  C  U 
aNucleotide numbering used for the New York flamingo 382-99 sequence 
(Genbank accession no. AF196835); locations of encoded amino acid differences 
are shown in parentheses. sequences of viruses isolated from Mexican states close to
the U.S. border, once obtained, may more closely resemble
strains isolated in Texas during 2002.
Of particular interest is the overlap in distribution of
WNV and VEEV (serologic data for VEEV not shown) in
the southern Mexican states of Veracruz and Yucatán; the
presence of other flaviviruses like SLEV in these states is
also likely. Both WNV and VEEV produce clinically sim-
ilar neurologic disease in horses, and past, presumptive
diagnoses of VEEV may have been inaccurate. Steps are
now in place at the Mexico City headquarters of the
Animal Health Division of SAGARPA to implement
appropriate laboratory diagnosis for flaviviruses and
alphaviruses. Additionally, field personnel are instructed to
investigate epidemiologic signs of possible WNVinfection
including avian death and unusual human neurologic syn-
dromes.
The biologic and epidemiologic consequences of mos-
quito-borne encephalitis viruses (12) cocirculating in the
same ecosystem should be examined. The impact of WNV
on human health in regions (such as Mexico) where inhab-
itants may have extensive prior exposure to other fla-
viviruses such as dengue, SLEV, Ilheus, Bussuquara,
Jutiapa, and Yellow fever viruses may differ from that in
regions (e.g., the United States and Canada) where human
exposure to flaviviruses is very limited. WNV infection in
persons with previous flavivirus immunity, which could
either attenuate disease because of cross-protective anti-
bodies (13) or potentially worsen disease because of
immune enhancement (14), should be studied. Our ongo-
ing VEEV surveillance in southern Mexico may identify
differences in transmission habitats for VEEV and WNV
and assist with optimizing virus containment efforts.
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